1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. Medtronic Acquires Lazarus Effect

M&A Deal Summary

Medtronic Acquires Lazarus Effect

On September 28, 2015, Medtronic acquired medical products company Lazarus Effect for 100M USD

Acquisition Highlights
  • This is Medtronic’s 36th transaction in the Medical Products sector.
  • This is Medtronic’s 31st largest (disclosed) transaction.
  • This is Medtronic’s 35th transaction in the United States.
  • This is Medtronic’s 16th transaction in California.

M&A Deal Summary
Date 2015-09-28
Target Lazarus Effect
Sector Medical Products
Buyer(s) Medtronic
Deal Type Add-on Acquisition
Deal Value 100M USD

Target

Lazarus Effect

Campbell, California, United States
Lazarus Effect, Inc. is a medical device company focused on acute ischemic stroke products that facilitate the capture and removal of clots.

Search 214,876 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Medtronic

Galway, Ireland
Category Company
Founded 1949
Sector Medical Products
Employees95,000
Revenue 33.5B USD (2025)
DESCRIPTION
Medtronic's operational headquarters in Fridley, Minnesota.
Medtronic's operational headquarters in Fridley, Minnesota.

Medtronic is a global medical technology company whose products aim to alleviate pain, restore health, and extend life. It serves hospitals, physicians, clinicians, and patients in approximately 160 countries worldwide. Medtronic was founded in 1949 and is based in Galway, Ireland with its operational headquarters in Fridley, Minnesota.

DEAL STATS #
Overall 41 of 59
Sector: Medical Products M&A 36 of 52
Type: Add-on Acquisition M&A Deals 40 of 57
State: California M&A 16 of 21
Country: United States M&A 35 of 44
Year: 2015 M&A 6 of 8
Size (of disclosed) 31 of 36
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-08-31 Medina Medical

Menlo Park, California, United States

Medina Medical, Inc. is a medical device company focused on commercializing state-of-the-art treatments for vascular abnormalities of the brain including cerebral aneurysms.

Buy $150M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-10-02 Twelve

Menlo Park, California, United States

Twelve, Inc. is a privately held medical device company focused on the development of a transcatheter mitral valve replacement (TMVR) device.

Buy $458M
Mergr

Solution for

Product

Company

Legal